Application Sponsors
ANDA 204868 | ACTAVIS LABS FL INC | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 4MG | 0 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE |
002 | TABLET, EXTENDED RELEASE;ORAL | 8MG | 0 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2015-04-29 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
ACTAVIS LABS FL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 204868
[companyName] => ACTAVIS LABS FL INC
[docInserts] => ["",""]
[products] => [{"drugName":"FESOTERODINE FUMARATE","activeIngredients":"FESOTERODINE FUMARATE","strength":"4MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"FESOTERODINE FUMARATE","activeIngredients":"FESOTERODINE FUMARATE","strength":"8MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/11\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-01-11
)
)